Krebs Biochemicals & Industries Stock Price - ₹57.88 | Healthcare

Announcements

Exchange filings, newest first

1 Oct
30 Sept
29 Sept

Documents by quarter

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

3 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

102 pages

Annual Reports 2024-25

76 pages

Annual Reports 2023-24

72 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

29 Sept 2026Krebs Biochemicals & Industries Ltd voting results of 34th AGM held on 29 Sep 2026 with scrutinizer's reportRecord Date

29 Sept 2026Krebs Biochemicals & Industries Ltd outcome of 34th AGM held on 29 Sep 2026Record Date

29 May 2026Krebs Biochemicals & Industries Limited submission of Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on May 29, 2026Audit Reports